Cardiovascular outcomes according to LDL cholesterol levels in EMPA-REG OUTCOME

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: A perspective on the effects of Empaglifozin in cardiovascular outcomes Drug therapy ESC Premium Access ESC Congress 2016

ESC 365 is supported by

ESC 365 is supported by